Fate Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of programmed cellular immunotherapies for cancer and immune disorders.
$83.13 -5.36 (-6.06%)
As of 03/04/2021 15:59:53 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.